Castlight Health, Inc. Class BFind Ratings Reports
CASTLIGHT HEALTH INC's gross profit margin for the second quarter of its fiscal year 2020 has increased when compared to the same period a year ago. Even though sales decreased, the net income has increased.
At the same time, stockholders' equity ("net worth") has significantly decreased by 36.10% from the same quarter last year.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q2 FY20||Q2 FY19|
|Net Sales ($mil)||35.5||35.91|
|Net Income ($mil)||-4.2||-8.38|
|Balance Sheet||Q2 FY20||Q2 FY19|
|Cash & Equiv. ($mil)||44.46||63.93|
|Total Assets ($mil)||172.27||257.07|
|Total Debt ($mil)||17.04||22.13|
|Profitability||Q2 FY20||Q2 FY19|
|Gross Profit Margin||68.61||63.49|
|Return on Assets||-47.37||-11.75|
|Return on Equity||-68.49||-16.2|
|Debt||Q2 FY20||Q2 FY19|
|Share Data||Q2 FY20||Q2 FY19|
|Shares outstanding (mil)||150.63||145.2|
|Div / share||0.0||0.0|
|Book value / share||0.79||1.28|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||415441.0||1393576.0|
SELL. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. For additional comparison, its price-to-book ratio of 1.57 indicates a significant discount versus the S&P 500 average of 3.87 and a significant discount versus the subsector average of 10.81. The price-to-sales ratio is well below both the S&P 500 average and the subsector average, indicating a discount. After reviewing these and other key valuation criteria, CASTLIGHT HEALTH INC proves to trade at a discount to investment alternatives.
|CSLT NM||Peers 100.51||CSLT NM||Peers 91.80|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
CSLT's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
CSLT's P/CF is negative making the measure meaningless.
|CSLT NM||Peers 70.20||CSLT NA||Peers 2.21|
Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.
CSLT's ratio is negative making this valuation measure meaningless.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|CSLT 1.57||Peers 10.81||CSLT -161.90||Peers -33.11|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
CSLT is trading at a significant discount to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, CSLT is expected to significantly trail its peers on the basis of its earnings growth rate.
|CSLT 1.28||Peers 19.54||CSLT -4.62||Peers 38.92|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
CSLT is trading at a significant discount to its subsector on this measurement.
Lower. A sales growth rate that trails the subsector implies that a company is losing market share.
CSLT significantly trails its peers on the basis of sales growth.